You may also like
COVID Convalescence—A Boon or Bane in Cardiac Surgery?: A “Second Hit” Hypothesis
A “convalescent COVID-19” patient with “first hit” at primary infection, encountering a “second hit” of surgery and perioperative insults, might have a hyperimmune response. This “second hit” hypothesis should be considered when COVID-19 convalescent (COVID-19 symptomatic or asymptomatic) patients undergo cardiac surgery and present with unusual complicatio
Retrograde Hot-Shot Cardioplegia in Patients With Left Ventricular Hypertrophy Undergoing Aortic Valve Replacement
Background: Intermittent antegrade cold-blood cardioplegia followed by terminal warm-blood cardioplegic reperfusion or hot-shot is reported to reduce myocardial injury in the setting […]
Potential Uses of Cord Blood in Cardiac Surgery
Umbilical cord blood, a rich source of multiple populations of nonembryonic stem cells, will be a valuable resource and has the potential to advance therapeutic options for patients with acquired and congenital heart disease.
